Suppr超能文献

一种新型的用于诱导性基因修饰的小鼠肾细升支模型。

A novel mouse model for an inducible gene modification in the renal thick ascending limb.

机构信息

Institute of Anatomy, University of Zurich, Zurich, Switzerland.

Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

出版信息

Am J Physiol Renal Physiol. 2023 May 1;324(5):F446-F460. doi: 10.1152/ajprenal.00250.2022. Epub 2023 Mar 9.

Abstract

The thick ascending limb (TAL) is critical for renal control of fluid and ion homeostasis. The function of the TAL depends on the activity of the bumetanide-sensitive Na-K-2Cl cotransporter (NKCC2), which is highly abundant in the luminal membrane of TAL cells. TAL function is regulated by various hormonal and nonhormonal factors. However, many of the underlying signal transduction pathways remain elusive. Here, we describe and characterize a novel gene-modified mouse model for an inducible and specific Cre/Lox-mediated gene modification in the TAL. In these mice, tamoxifen-dependent Cre (CreERT2) was inserted into the 3'-untranslated region of the Slc12a1 gene, which encodes NKCC2 (Slc12a1-CreERT2). Although this gene modification strategy slightly reduced endogenous NKCC2 expression at the mRNA and protein levels, the lowered NKCC2 abundance was not associated with altered urinary fluid and ion excretion, urinary concentration, and the renal response to loop diuretics. Immunohistochemistry on kidneys from Slc12a1-CreERT2 mice revealed strong Cre expression exclusively in TAL cells but not in any other nephron portion. Cross-breeding of these mice with the mT/mG reporter mouse line showed a very low recombination rate (∼0% in male mice and <3% in female mice) at baseline but complete (∼100%) recombination after repeated tamoxifen administration in male and female mice. The achieved recombination encompassed the entire TAL and also included the macula densa. Thus, the new Slc12a1-CreERT2 mouse line allows inducible and very efficient gene targeting in the TAL and hence promises to be a powerful tool to advance our understanding of the regulation of TAL function. The renal thick ascending limb (TAL) is critical for renal control of fluid and ion homeostasis. However, the underlying molecular mechanisms that regulate TAL function are incompletely understood. This study describes a novel transgenic mouse model (Slc12a1-creERT2) for inducible and highly efficient gene targeting in the TAL that promises to ease physiological studies on the functional role of candidate regulatory genes.

摘要

升支粗段(TAL)对于肾脏控制液体和离子稳态至关重要。TAL 的功能取决于布美他尼敏感的 Na-K-2Cl 共转运体(NKCC2)的活性,该蛋白在 TAL 细胞的腔膜中高度丰富。TAL 的功能受各种激素和非激素因素的调节。然而,许多潜在的信号转导途径仍然难以捉摸。在这里,我们描述并表征了一种新型的基因修饰小鼠模型,用于 TAL 中诱导型和特异性 Cre/Lox 介导的基因修饰。在这些小鼠中,他莫昔芬依赖性 Cre(CreERT2)被插入编码 NKCC2(Slc12a1-CreERT2)的 Slc12a1 基因的 3'-非翻译区。尽管这种基因修饰策略略微降低了内源性 NKCC2 在 mRNA 和蛋白质水平上的表达,但降低的 NKCC2 丰度与尿液流体和离子排泄、尿液浓缩以及肾脏对袢利尿剂的反应没有关联。来自 Slc12a1-CreERT2 小鼠的肾脏免疫组织化学显示,Cre 表达仅在 TAL 细胞中强烈表达,但在任何其他肾单位部分均不表达。这些小鼠与 mT/mG 报告小鼠系杂交显示,在基线时雄性小鼠的重组率非常低(约 0%),而雌性小鼠的重组率低于 3%,但在雄性和雌性小鼠反复给予他莫昔芬后完全(约 100%)重组。实现的重组涵盖了整个 TAL,还包括了致密斑。因此,新的 Slc12a1-CreERT2 小鼠系允许在 TAL 中进行诱导性和非常高效的基因靶向,因此有望成为推进我们对 TAL 功能调节理解的有力工具。肾脏升支粗段(TAL)对于肾脏控制液体和离子稳态至关重要。然而,调节 TAL 功能的潜在分子机制尚不完全清楚。本研究描述了一种新型的转基因小鼠模型(Slc12a1-creERT2),用于在 TAL 中进行诱导性和高效的基因靶向,有望简化候选调节基因功能的生理研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6431/10085568/e27380bca3fe/f-00250-2022r01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验